|
Volumn 22, Issue 7 Suppl, 2008, Pages 4-8
|
Agomelatine, an innovative pharmacological response to unmet needs.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETAMIDE DERIVATIVE;
AGOMELATINE;
ANTIDEPRESSANT AGENT;
MELATONIN 1 RECEPTOR;
MELATONIN 2 RECEPTOR;
SEROTONIN 2C RECEPTOR;
SEROTONIN ANTAGONIST;
ANIMAL;
ANIMAL MODEL;
CHRONIC DISEASE;
CIRCADIAN RHYTHM;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
HUMAN;
MAJOR DEPRESSION;
PATHOPHYSIOLOGY;
PSYCHOLOGICAL ASPECT;
RECURRENT DISEASE;
REVIEW;
TREATMENT OUTCOME;
ACETAMIDES;
ANIMALS;
ANTIDEPRESSIVE AGENTS;
CHRONIC DISEASE;
CIRCADIAN RHYTHM;
DEPRESSIVE DISORDER, MAJOR;
HUMANS;
MODELS, ANIMAL;
RECEPTOR, MELATONIN, MT1;
RECEPTOR, MELATONIN, MT2;
RECEPTOR, SEROTONIN, 5-HT2C;
RECURRENCE;
SEROTONIN ANTAGONISTS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 70449835855
PISSN: None
EISSN: 14617285
Source Type: Journal
DOI: 10.1177/0269881108092593 Document Type: Review |
Times cited : (10)
|
References (53)
|